Influenza Virus Infection in Guinea Pigs Raised as Livestock, Ecuador
Victor H. Leyva-Grado, Samira Mubareka, Florian Krammer, Washington B. Cárdenas, and Peter Palese
Author affiliations: Mount Sinai School of Medicine, New York, New York, USA (V.H. Leyva-Grado, F. Krammer, P. Palese); Sunnybrook Health Sciences Centre and Research Institute, Toronto, Ontario, Canada (S. Mubareka); and; Escuela Superior Politécnica del Litoral (ESPOL), Guayaquil, Ecuador (W.B. Cárdenas)
Figure 2. . . . Results of Western blot analyses of pooled serum samples from adult guinea pigs in Ecuador. The guinea pigs were obtained from farms in Cuenca, where they had been raised as livestock, or from live animal markets in Guayaquil and Manabí. The results show different influenza antigens: recombinant hemagglutinin (rHA) A/New Caledonia/20/1999 (A); rHA A/Wisconsin/67/2005 (B); rHA A/Vietnam/1203/2004 (C); recombinant nucleoprotein A/Puerto Rico/08/1934 (D); and B virus (whole virus B/Yamagata/16/1988) (E). Molecular weights are shown at left. (+), serum from guinea pigs infected in the laboratory with influenza virus; (−), serum from naive guinea pig; lanes 1–4, pooled serum samples from Cuenca; lanes 5–6, pooled serum samples from Guayaquil; lanes 7–8, pooled serum samples from Manabí; S, secondary antibody only.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.